---
source: Pascal Soriot, CEO of AstraZeneca
---
Cambridge competes on the global stage as a respected innovation hub for life sciences. Being part of this ecosystem means that our people are able to rub shoulders with some of the world’s leading research – that’s a really exciting prospect.”